<?xml version="1.0" encoding="UTF-8"?>
<p class="p">According to a nonrandomized controlled trials, 57 patients who were allocated to receive 2 g daily supplementations of black cumin for one year displayed a noticeable reduction in systolic, diastolic, and mean arterial BP, heart rate, TC, LDL-c, the fractions of TC/HDL-c, and LDL-c/HDL-c while serum HDL-c was suggestively raised compared with the corresponding baseline values and the control group [
 <xref rid="B53" ref-type="bibr" class="xref">53</xref>]. Although a trend towards reduction in BP was observed after
 <italic class="italic"> N. sativa </italic>administration, one randomized controlled clinical trial failed to show a significant reduction of BP in elderly patients with hypertension [
 <xref rid="B54" ref-type="bibr" class="xref">54</xref>]. This might be because of the sample size, dosage (300 mg BID for 4 weeks) of the
 <italic class="italic"> N. sativa</italic> used in this study, the severity of hypertension, and study population used. For instance, previous clinical studies conducted by Dehkordi et al. [
 <xref rid="B55" ref-type="bibr" class="xref">55</xref>] and Qidwai et al. [
 <xref rid="B56" ref-type="bibr" class="xref">56</xref>] conducted on mild hypertensive patients with the dosage of 200 mg BID for 4 weeks and 500 mg BID for 6 weeks, respectively, showed a significant reduction of SPB.
</p>
